These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 12476796)

  • 1. Molecular basis for designing selective modulators of retinoic acid receptor transcriptional activities.
    Lefebvre P
    Curr Drug Targets Immune Endocr Metabol Disord; 2001 Aug; 1(2):153-64. PubMed ID: 12476796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conformationally defined 6-s-trans-retinoic acid analogs. 3. Structure-activity relationships for nuclear receptor binding, transcriptional activity, and cancer chemopreventive activity.
    Muccio DD; Brouillette WJ; Alam M; Vaezi MF; Sani BP; Venepally P; Reddy L; Li E; Norris AW; Simpson-Herren L; Hill DL
    J Med Chem; 1996 Sep; 39(19):3625-35. PubMed ID: 8809153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The retinoid X receptor and its ligands: versatile regulators of metabolic function, cell differentiation and cell death.
    Ahuja HS; Szanto A; Nagy L; Davies PJ
    J Biol Regul Homeost Agents; 2003; 17(1):29-45. PubMed ID: 12757020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of ligand binding on the association properties and conformation in solution of retinoic acid receptors RXR and RAR.
    Egea PF; Rochel N; Birck C; Vachette P; Timmins PA; Moras D
    J Mol Biol; 2001 Mar; 307(2):557-76. PubMed ID: 11254382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design of selective nuclear receptor modulators: RAR and RXR as a case study.
    de Lera AR; Bourguet W; Altucci L; Gronemeyer H
    Nat Rev Drug Discov; 2007 Oct; 6(10):811-20. PubMed ID: 17906643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corepressor interaction differentiates the permissive and non-permissive retinoid X receptor heterodimers.
    Lammi J; Perlmann T; Aarnisalo P
    Arch Biochem Biophys; 2008 Apr; 472(2):105-14. PubMed ID: 18282463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The retinoid ligand 4-oxo-retinoic acid is a highly active modulator of positional specification.
    Pijnappel WW; Hendriks HF; Folkers GE; van den Brink CE; Dekker EJ; Edelenbosch C; van der Saag PT; Durston AJ
    Nature; 1993 Nov; 366(6453):340-4. PubMed ID: 8247127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RAR and RXR modulation in cancer and metabolic disease.
    Altucci L; Leibowitz MD; Ogilvie KM; de Lera AR; Gronemeyer H
    Nat Rev Drug Discov; 2007 Oct; 6(10):793-810. PubMed ID: 17906642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of apoptosis in MCF-7 breast carcinoma cell line by RAR and RXR selective retinoids.
    Toma S; Isnardi L; Riccardi L; Bollag W
    Anticancer Res; 1998; 18(2A):935-42. PubMed ID: 9615744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new class of retinoids with selective inhibition of AP-1 inhibits proliferation.
    Fanjul A; Dawson MI; Hobbs PD; Jong L; Cameron JF; Harlev E; Graupner G; Lu XP; Pfahl M
    Nature; 1994 Nov; 372(6501):107-11. PubMed ID: 7969403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuclear retinoid receptors and the transcription of retinoid-target genes.
    Bastien J; Rochette-Egly C
    Gene; 2004 Mar; 328():1-16. PubMed ID: 15019979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utilization of DR1 as true RARE in regulating the Ssm, a novel retinoic acid-target gene in the mouse testis.
    Han K; Song H; Moon I; Augustin R; Moley K; Rogers M; Lim H
    J Endocrinol; 2007 Mar; 192(3):539-51. PubMed ID: 17332523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of lipid and lipoprotein metabolism by retinoids.
    Staels B
    J Am Acad Dermatol; 2001 Nov; 45(5):S158-67. PubMed ID: 11606948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A decade of molecular biology of retinoic acid receptors.
    Chambon P
    FASEB J; 1996 Jul; 10(9):940-54. PubMed ID: 8801176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Action mechanism of retinoid-synergistic dibenzodiazepines.
    Umemiya H; Kagechika H; Fukasawa H; Kawachi E; Ebisawa M; Hashimoto Y; Eisenmann G; Erb C; Pornon A; Chambon P; Gronemeyer H; Shudo K
    Biochem Biophys Res Commun; 1997 Apr; 233(1):121-5. PubMed ID: 9144408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptional activities of retinoic acid receptors.
    Lefebvre P; Martin PJ; Flajollet S; Dedieu S; Billaut X; Lefebvre B
    Vitam Horm; 2005; 70():199-264. PubMed ID: 15727806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RXR: from partnership to leadership in metabolic regulations.
    Desvergne B
    Vitam Horm; 2007; 75():1-32. PubMed ID: 17368310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of retinoid X receptor-selective ligands on proliferation of prostate cancer cells.
    de Vos S; Dawson MI; Holden S; Le T; Wang A; Cho SK; Chen DL; Koeffler HP
    Prostate; 1997 Jul; 32(2):115-21. PubMed ID: 9215399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of nuclear retinoid receptors in normal, premalignant and malignant gastric tissues determined by in situ hybridization.
    Jiang SY; Shen SR; Shyu RY; Yu JC; Harn HJ; Yeh MY; Lee MM; Chang YC
    Br J Cancer; 1999 Apr; 80(1-2):206-14. PubMed ID: 10389997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of synthetic retinoids with selectivity for retinoic acid or retinoid X nuclear receptors.
    LeMotte PK; Keidel S; Apfel CM
    Biochim Biophys Acta; 1996 Mar; 1289(2):298-304. PubMed ID: 8600988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.